✦ LIBER ✦

Investigation of clinical characteristics as predictive factors for the humoral immune response to the influenza vaccine in patients with rheumatoid arthritis

✍ Scribed by Kogure, Toshiaki; Harada, Naoyuki; Tatsumi, Takeshi; Fujinaga, Hiroshi

Book ID: 121538224
Publisher: Springer
Year: 2014
Tongue: English
Weight: 145 KB
Volume: 33
Category: Article
ISSN: 0770-3198
DOI: 10.1007/s10067-013-2483-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The cellular immune response to influenz

The cellular immune response to influenza vaccination is preserved in rheumatoid arthritis patients treated with rituximab

✍ U. Arad; S. Tzadok; S. Amir; M. Mandelboim; E. Mendelson; I. Wigler; H. Sarbagil 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 661 KB

Anti-tumor necrosis factor therapy does

Anti-tumor necrosis factor therapy does not diminish the immune response to influenza vaccine in Japanese patients with rheumatoid arthritis

✍ Tetsuo Kubota; Tokiko Nii; Toshihiro Nanki; Hitoshi Kohsaka; Masayoshi Harigai; 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 240 KB

The Effect of Infliximab and Timing of V

The Effect of Infliximab and Timing of Vaccination on the Humoral Response to Influenza Vaccination in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis

✍ Ori Elkayam; Amir Bashkin; Michal Mandelboim; Irena Litinsky; Doron Comaheshter; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 258 KB

The Effect of tumor necrosis factor bloc

The Effect of tumor necrosis factor blockade on the response to pneumococcal vaccination in patients with rheumatoid arthritis and ankylosing spondylitis

✍ Ori Elkayam; Dan Caspi; Tatiana Reitblatt; Darlene Charboneau; Jeffrey B. Rubins 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 71 KB

CCL19, a B Cell Chemokine, Is Related to

CCL19, a B Cell Chemokine, Is Related to the Decrease of Blood Memory B Cells and Predicts the Clinical Response to Rituximab in Patients With Rheumatoid Arthritis

✍ Sellam, Jérémie; Rouanet, Stéphanie; Hendel-Chavez, Houria; Miceli-Richard, Cori 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB

THE 3-MONTH CLINICAL RESPONSE TO INTRAVE

THE 3-MONTH CLINICAL RESPONSE TO INTRAVESICAL THERAPY AS A PREDICTIVE FACTOR FOR PROGRESSION IN PATIENTS WITH HIGH RISK SUPERFICIAL BLADDER CANCER

✍ SOLSONA, E.; IBORRA, I.; DUMONT, R.; RUBIO-BRIONES, J.; CASANOVA, J.; ALMENAR, S 📂 Article 📅 2000 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 61 KB